Comparative Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Elderly Patients with Severe Symptomatic Aortic Stenosis: A Systematic Review
Journal of the Saudi Heart Association · 11.10.2024 · 36 (3) · 242-251
DOI: 10.37616/2212-5043.1393 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the Saudi Heart Association, online erschienen am 11.10.2024. Verfasst von Omar Hamodat und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Sharjah, College of Medicine, Sharjah, UAE. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Aortic stenosis is the most common valvular heart disease globally; while transcatheter aortic valve replacement (TAVR) has proven to be a competitive alternative to surgical aortic valve replacement (SAVR) and revolutionized treatment, its safety and efficacy has yet to be comprehensively assessed against SAVR for certain subsets of aortic stenosis patients; therefore, this study aims to systematically analyze all the available clinical evidence from randomized clinical trials on TAVR versus SAVR among intermediate and low-risk patients with severe symptomatic aortic stenosis. Methodology: We performed a systematic review of the randomized controlled trials (RCT), studies comparing TAVR and SAVR in low- and intermediate-risk patients were identified by a comprehensive search of the major databases. Mortality, stroke, length of stay, and other perioperative outcomes were assessed.
Results
A comprehensive screening of 14,384 records identified 9 studies, encompassing 8,884 patients with a mean age of 77.76 years and 49.47% male. TAVR demonstrated a significantly lower all-cause mortality at both 30 days and 1 year compared to SAVR, with comparable outcomes at 2 years, underscoring its potential for enhanced survival. Stroke incidence was markedly lower with TAVR at both 30 days and 1 year, highlighting its favorable neurological safety profile. Additionally, TAVR showed a reduced rate of myocardial infarction within the initial 30 days post-procedure. Prosthetic valve endocarditis rates remained low and comparable between the two approaches at both 30 days and 1 year. Notably, TAVR was associated with a significantly shorter hospital stay, suggesting a faster recovery trajectory and improved patient throughput. These findings collectively emphasize the superior efficacy and safety profile of TAVR over SAVR.
Conclusion
TAVR may serve as a viable therapeutic option for intermediate and low-risk patients with severe symptomatic aortic stenosis. Future research should focus on long-term outcomes and TAVR device durability, especially in younger, lower-risk populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Sharjah, College of Medicine, Sharjah, UAE.
Zitieren
APA
Hamodat, O., Almuzainy, S., & Nizar, S. (2024). Comparative Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Elderly Patients with Severe Symptomatic Aortic Stenosis: A Systematic Review. Journal of the Saudi Heart Association, 36(3), 242-251. https://doi.org/10.37616/2212-5043.1393
Vancouver
Hamodat O, Almuzainy S, Nizar S. Comparative Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Elderly Patients with Severe Symptomatic Aortic Stenosis: A Systematic Review. Journal of the Saudi Heart Association. 2024;36(3):242-251. doi:10.37616/2212-5043.1393
BibTeX
@article{Hamodat2024,
author = {Hamodat, Omar and Almuzainy, Saif and Nizar, Salma},
title = {Comparative Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Elderly Patients with Severe Symptomatic Aortic Stenosis: A Systematic Review},
journal = {Journal of the Saudi Heart Association},
year = {2024},
volume = {36},
number = {3},
pages = {242--251},
doi = {10.37616/2212-5043.1393}
}
EUVIMED